The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Inactivated Polio And Rabies Vaccines Market Over The 2026–2030 Period?
The market size for inactivated polio and rabies vaccines has seen robust growth in recent years. This market is anticipated to expand from $2.27 billion in 2025 to $2.4 billion in 2026, showing a compound annual growth rate (CAGR) of 5.5%. The expansion witnessed in prior periods can be attributed to global initiatives for polio eradication, an increase in rabies occurrences from animal bites, the enlargement of national immunization schemes, greater public sector procurement of vaccines, and vaccination directives from WHO and UNICEF.
The inactivated polio and rabies vaccines market is set for significant expansion in the coming years, with its size projected to reach $2.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.5%. This growth throughout the forecast period stems from various factors, including an intensified focus on achieving zero rabies deaths, increasing pediatric immunization coverage in emerging economies, improved access to healthcare in rural areas, an expanding demand for adult post-exposure prophylaxis, and bolstered pandemic preparedness infrastructure. Furthermore, major developments expected during this period involve the expansion of combination ipv and rabies immunization programs, a shift towards intradermal rabies vaccination for optimizing doses, strengthening of cold chain and vaccine logistics infrastructure, an increase in government-led mass immunization campaigns, and a rising adoption of WHO-prequalified inactivated vaccines.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24252&type=smp
Which Economic Or Industry Drivers Are Impacting The Inactivated Polio And Rabies Vaccines Market?
The increasing need for effective vaccination programs is anticipated to drive the expansion of the inactivated polio and rabies vaccines market moving forward. A vaccination program involves a structured effort by a collective or governmental body to provide vaccines to individuals for disease prevention. The rise in these programs stems from heightened government initiatives to prevent outbreaks, minimize healthcare expenditures, and enhance public health. Vaccination programs elevate the demand for inactivated polio and rabies vaccines by improving awareness, securing funding, and expanding coverage in areas at high risk. Consistent vaccine uptake is sustained through widespread campaigns and routine immunizations led by governments and health organizations. For example, in April 2024, the Pan American Health Organization (PAHO), a US-based specialized agency, launched the 22nd Vaccination Week in the Americas (VWA) with the theme “Engage now to protect your future GetVax,” targeting the administration of over 65 million doses to increase vaccination coverage, especially in underserved regions. This initiative focused on countering misinformation and improving vaccine access through community engagement and customized campaigns. Therefore, the growing demand for effective vaccination programs is a significant factor propelling the growth of the inactivated polio and rabies vaccines market.
How Is The Inactivated Polio And Rabies Vaccines Market Segmented Across Key Categories?
The inactivated polio and rabies vaccines market covered in this report is segmented –
1) By Product Type: Inactivated Polio Vaccine, Inactivated Rabies Vaccine
2) By Method Of Inactivation: Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, Other Method Of Inactivations
3) By Distribution Channel: Government, Private
4) By Application: Pediatrics, Adults
Subsegments:
1) By Inactivated Polio Vaccine: Injectable Inactivated Polio Vaccine, Oral Inactivated Polio Vaccine
2) By Inactivated Rabies Vaccine: Injectable Inactivated Rabies Vaccine, Intradermal Inactivated Rabies Vaccine
Which Upcoming Trends Are Expected To Influence The Inactivated Polio And Rabies Vaccines Market?
Major companies in the inactivated polio and rabies vaccines market are concentrating on developing advanced products, including killed virus rabies vaccines, to enhance immunogenicity and address the growing global demand for effective disease prevention. Killed virus rabies vaccines are manufactured by rendering the rabies virus non-infectious through chemical or physical processes. These vaccines stimulate the immune system to produce protective antibodies without inducing the disease, thus ensuring their safety and effectiveness in both pre- and post-exposure prophylaxis. For example, in April 2024, Sanofi, a UK-based pharmaceutical company, launched Verorab, an inactivated rabies vaccine, in the UK for the pre-exposure and post-exposure prophylaxis of rabies across all age groups. The vaccine, licensed in the UK based on comprehensive clinical data from over 13,000 individuals, has already been extensively used in more than 80 countries. Verorab offers an effective immunization solution for travelers visiting high-risk countries and for treatment following rabies exposure, with clinical trials demonstrating strong immune responses and long-lasting protection.
Who Are The Dominant Players Shaping The Inactivated Polio And Rabies Vaccines Market Landscape?
Major companies operating in the inactivated polio and rabies vaccines market are Merck & Co Inc., Sanofi S.A., LG Chem Ltd., Boehringer Ingelheim International GmbH, Sinovac Biotech, Zoetis Inc., Cadila Pharmaceuticals, Zydus Lifesciences Limited, Biological E. Limited, Serum Institute of India (SII), Indian Immunologicals Limited (IIL), Instituto Butantan, Valneva SE, Bio Farma, Bharat Biotech, Bilthoven Biologicals, Panacea Biotec, Batavia Biosciences, Hilleman Laboratories, China National Pharmaceutical Group Co Ltd.
Read the full inactivated polio and rabies vaccines market report here:
What Are The Top-Performing Regions Within The Inactivated Polio And Rabies Vaccines Market?
North America was the largest region in the inactivated polio and rabies vaccines market in 2025. The regions covered in the inactivated polio and rabies vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Inactivated Polio And Rabies Vaccines Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24252&type=smp
Browse Through More Reports Similar to the Global Inactivated Polio And Rabies Vaccines Market 2026, By The Business Research Company
Preventive Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/preventive-vaccines-global-market-report
Preventive Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/preventive-vaccines-global-market-report
Inactivated Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model